Ensink F B, Bautz M T, Hirn A M, Nass S, Kettler D, Hanekop G G
Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Georg-August-Universität Göttingen.
Zentralbl Chir. 1998;123(6):649-63.
Like other industrial countries Germany experiences a significant increase of cancer prevalence. Recent advances in the treatment of various types of cancer resulted in prolonged survivaltimes of patients. Cancer--especially in advanced incurable stages--often is accompanied by severe pain. Therefore, the need for sufficient pain management and symptomcontrol is obvious. Throughout the last decades new drugs and techniques for the management of cancer-pain have been developed. Most cancer-patients should experience sufficient pain-management if existing recommendations for the pharmacological treatment of cancer-pain (e.g. WHO-guidelines) are followed consequently. In case of intractable pain or ongoing disabling symptoms despite proper therapy consultation of an expert in palliative medicine should always be considered as well as the option to refer the patient to a specialized pain-management center.
与其他工业国家一样,德国的癌症患病率显著上升。各类癌症治疗方面的最新进展使患者的生存时间得以延长。癌症——尤其是在晚期无法治愈阶段——常常伴有剧痛。因此,进行充分的疼痛管理和症状控制的必要性显而易见。在过去几十年里,已研发出用于管理癌痛的新药和新技术。如果严格遵循现有的癌症疼痛药物治疗建议(例如世界卫生组织的指南),大多数癌症患者应能获得充分的疼痛管理。对于顽固性疼痛或尽管经过适当治疗仍持续存在的致残症状,始终应考虑咨询姑息医学专家,并考虑将患者转诊至专门的疼痛管理中心。